Lawsuit settlement funding company Legal-Bay has announced that the first two bellwether trials of Granuflo and Naturalyte lawsuits will take place in January and February of 2016.
According to Drug Watch, over 1,800 lawsuits have been consolidated into multidistrict litigation (MDL) under U.S. District Judge Douglas P. Woodlock in the District of Massachusetts. The first trial is set to start on January 11th, 2016, with the second bellwether trial starting on February 16th, 2016 (In re: Fresenius GranuFlo/NaturaLyte Dialysate Litigation, MDL No. 2428). The lawsuits against Fresenius Medical Care Inc. claim that the company knew of the danger in their products and failed to adequately warn and inform the public, and there are also allegations that they neglected to warn health care providers as well as properly train them on how to use these dialysis products safely. The lawsuits allege that Fresenius Medical Care failed to warn dialysis clinics – outside its own Fresenius clinics – of potential Alkali Dosing Errors. Claims against Fresenius Medical Care include patients who have suffered injury or death as a result of using GranuFlo and/or NaturaLyte products during hemodialysis. GranuFlo and NaturaLyte are dialysates used in thousands of dialysis centers to treat patients with kidney disease or failure. Potential injuries and complications from GranuFlo and NaturaLyte products include: heart attack, cardiopulmonary arrest, stroke, and death. A version of this content was originally posted by PR Newswire on Sys-Con.com. Granuflo and Naturalyte Lawsuits – Ball & Evans & Ball & Evans Trial Attorney – Los Angeles
